ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,216.86
0.20%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Therapeutics Acquisition Corp (RACA)

  7. Therapeutics Acquisition Corp (RACA) Noticias

RACA

Therapeutics Acquisition (RACA)

Therapeutics Acquisition Corp
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:RACA
FechaHoraFuenteTítuloSímboloCompañía
14/06/202317:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RACATherapeutics Acquisition Corp
14/06/202317:15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:RACATherapeutics Acquisition Corp
05/06/202315:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RACATherapeutics Acquisition Corp
01/05/202312:58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:RACATherapeutics Acquisition Corp
27/04/202307:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RACATherapeutics Acquisition Corp
27/03/202306:55Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RACATherapeutics Acquisition Corp
14/02/202311:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RACATherapeutics Acquisition Corp
03/02/202311:12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RACATherapeutics Acquisition Corp
22/11/202215:22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RACATherapeutics Acquisition Corp
14/11/202206:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RACATherapeutics Acquisition Corp
14/09/202215:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:RACATherapeutics Acquisition Corp
12/08/202207:23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RACATherapeutics Acquisition Corp
12/07/202205:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RACATherapeutics Acquisition Corp
01/07/202215:14Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:RACATherapeutics Acquisition Corp
16/05/202207:28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:RACATherapeutics Acquisition Corp
17/03/202218:20Edgar (US Regulatory)Amended Annual Statement of Changes in Beneficial Ownership (5/a)NASDAQ:RACATherapeutics Acquisition Corp
14/02/202217:53Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:RACATherapeutics Acquisition Corp
08/02/202213:25Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:RACATherapeutics Acquisition Corp
30/07/202115:52Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:RACATherapeutics Acquisition Corp
12/07/202115:38Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:RACATherapeutics Acquisition Corp
08/07/202110:39Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:RACATherapeutics Acquisition Corp
30/06/202115:05GlobeNewswire Inc.POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics CompanyNASDAQ:RACATherapeutics Acquisition Corp
21/06/202115:03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:RACATherapeutics Acquisition Corp
09/06/202115:30Business WireResearch Alliance Corp. I Announces Effectiveness of Registration Statement for Proposed Business Combination with POINTNASDAQ:RACATherapeutics Acquisition Corp
07/06/202105:01Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:RACATherapeutics Acquisition Corp
04/06/202107:30Business WirePOINT Biopharma Announces First Patients Dosed in Phase 3 Study of PNT2002 for mCRPCNASDAQ:RACATherapeutics Acquisition Corp
01/06/202115:31Business WirePOINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana FacilityNASDAQ:RACATherapeutics Acquisition Corp
23/03/202105:07Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:RACATherapeutics Acquisition Corp
18/03/202108:09Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:RACATherapeutics Acquisition Corp
08/12/202009:17GlobeNewswire Inc.Cerevance Appoints David Lubner to Board of DirectorsNASDAQ:RACATherapeutics Acquisition Corp
 Showing the most relevant articles for your search:NASDAQ:RACA

Su Consulta Reciente

CCOM
US500
US 500
AMEX
SPY
SPDR S&P 500
COIN
SOLUSD
Solana
USI
USTECH100
US Tech 100
NYSE
CVX
Chevron
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BASFY
BASF (QX)
NYSE
JPM
JP Morgan Chase
AMEX
XLF
Financial Select Sector
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
MSFT
Microsoft
NYSE
AXP
American Express
NYSE
DIS
Walt Disney
NYSE
BAC
Bank of America
FX
USDMXN
US Dollar vs MXN
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados